IMI (Inverness Medical Innovations) completes buy of Apogent's Applied Biotech:
This article was originally published in Clinica
Inverness Medical Innovations (IMI) has completed its acquisition of San Diego, California-based Applied Biotech, the rapid diagnostic test manufacturing subsidiary of Apogent Technologies. The deal releases Apogent from any further patent infringement claims by IMI relating to products sold by Apogent before the acquisition closed. Apogent decided to sell the unit because of its exposure to IMI's patent protection action in the fields of rapid pregnancy, drugs of abuse and infection testing (see Clinica No 1069, p 15).